Erik Magnus Ohman, MBBS

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 8678A Hafs Bldg, Durham, NC 27710
Phone (919) 681-2069
Email address ohman001@mc.duke.edu

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices. 

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology.  He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology. 

Education and Training

  • M.B.B.S., Royal College of Surgeons (Ireland), 1981

Publications

Povsic, Thomas J., Timothy D. Henry, E Magnus Ohman, Carl J. Pepine, Ronald G. Crystal, Todd K. Rosengart, Rickey R. Reinhardt, et al. “Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.” Am Heart J 241 (November 2021): 38–49. https://doi.org/10.1016/j.ahj.2021.06.013.

PMID
34224684
Full Text

Sullivan, Alexander E., Michael G. Nanna, Tracy Y. Wang, Deepak L. Bhatt, Dominick J. Angiolillo, Roxana Mehran, Subhash Banerjee, et al. “Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.” J Am Coll Cardiol 78, no. 15 (October 12, 2021): 1550–63. https://doi.org/10.1016/j.jacc.2021.08.013.

PMID
34620413
Full Text

Picard, Fabien, Deepak L. Bhatt, Grégory Ducrocq, E Magnus Ohman, Shinya Goto, Kim A. Eagle, Peter W. F. Wilson, Sidney C. Smith, Yedid Elbez, and Philippe Gabriel Steg. “Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry.” Int J Cardiol 340 (October 1, 2021): 96–104. https://doi.org/10.1016/j.ijcard.2021.08.031.

PMID
34450192
Full Text

O’Neill, Brian P., Cindy Grines, Jeffrey W. Moses, E Magnus Ohman, Alexandra Lansky, Jeffery Popma, Navin K. Kapur, et al. “Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.” Catheter Cardiovasc Interv 98, no. 4 (October 2021): E501–12. https://doi.org/10.1002/ccd.29758.

PMID
34051033
Full Text

Vogel, Birgit, Usman Baber, David J. Cohen, Samantha Sartori, Samin K. Sharma, Dominick J. Angiolillo, Serdar Farhan, et al. “Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.” Jama Cardiol 6, no. 9 (September 1, 2021): 1032–41. https://doi.org/10.1001/jamacardio.2021.1720.

PMID
33991416
Full Text

Madhavan, Mahesh V., Behnood Bikdeli, Björn Redfors, Giuseppe Biondi-Zoccai, Nicholas J. Varunok, John R. Burton, Aaron Crowley, et al. “Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials.” Minerva Cardiol Angiol 69, no. 4 (August 2021): 398–407. https://doi.org/10.23736/S0026-4725.20.05353-0.

PMID
33258563
Full Text

Angiolillo, Dominick J., Davide Cao, Usman Baber, Samantha Sartori, Zhongjie Zhang, George Dangas, Shamir Mehta, et al. “Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.” Jacc Cardiovasc Interv 14, no. 13 (July 12, 2021): 1434–46. https://doi.org/10.1016/j.jcin.2021.04.043.

PMID
34238553
Full Text

Ohman, E Magnus, Brittany A. Zwischenberger, and Holger Thiele. “Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better.” Jacc Cardiovasc Interv 14, no. 10 (May 24, 2021): 1120–22. https://doi.org/10.1016/j.jcin.2021.04.016.

PMID
34016409
Full Text

Pages